Fagret D - Search Results

1

Study of inter- and intra-observer reproducibility in the interpretation of [(18)F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment.

Pegard C, Gallazzini-Crépin C, Giai J, Dubreuil J, Caoduro C, Desruet MD, Roux J, Calizzano A, Fagret D, Lamesa C, Boulahdour H, Vuillez JP. Pegard C, et al. Among authors: fagret d. EJNMMI Res. 2014 May 30;4:25. doi: 10.1186/s13550-014-0025-7. eCollection 2014. EJNMMI Res. 2014. PMID: 25006544 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 38245296

3

Coronary Physiology: Delivering Precision Medicine?

Maitre-Ballesteros L, Riou L, Marliere S, Canu M, Vautrin E, Piliero N, Ormezzano O, Bouvaist H, Broisat A, Ghezzi C, Fagret D, Vanzetto G, Djaïleb L, Barone-Rochette G. Maitre-Ballesteros L, et al. Among authors: fagret d. Rev Cardiovasc Med. 2022 Apr 27;23(5):158. doi: 10.31083/j.rcm2305158. eCollection 2022 May. Rev Cardiovasc Med. 2022. PMID: 39077613 Free PMC article. Review.

4

Can tumour marker assays be a guide in the prescription of bone scan for breast and lung cancers?

Buffaz PD, Gauchez AS, Caravel JP, Vuillez JP, Cura C, Agnius-Delord C, Fagret D. Buffaz PD, et al. Among authors: fagret d. Eur J Nucl Med. 1999 Jan;26(1):8-11. doi: 10.1007/s002590050352. Eur J Nucl Med. 1999. PMID: 9933655

5

In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors.

Buffaz PD, Vuillez JP, Chabre O, Cura C, Barnoud R, Pasquier D, Dupre A, Fagret D. Buffaz PD, et al. Among authors: fagret d. Clin Nucl Med. 1999 Jun;24(6):459-60. doi: 10.1097/00003072-199906000-00024. Clin Nucl Med. 1999. PMID: 10361953 No abstract available.

6

Potential use of radiolabeled antisense oligonucleotides in oncology.

Gauchez AS, Du Moulinet D'Hardemare A, Lunardi J, Vuillez JP, Fagret D. Gauchez AS, et al. Among authors: fagret d. Anticancer Res. 1999 Nov-Dec;19(6B):4989-97. Anticancer Res. 1999. PMID: 10697501 Review.

7

Early detection of chemoresistance in vivo through the use of a radiolabeled antisense oligonucleotide.

Touboul M, Gauchez AS, D'Hardemare Adu M, Lunardi J, Deverre JR, Pernin C, Mathieu JP, Vuillez JP, Fagret D. Touboul M, et al. Among authors: fagret d, d hardemare adu m. Anticancer Res. 2002 Nov-Dec;22(6A):3349-56. Anticancer Res. 2002. PMID: 12530086

8

Cellular uptake of (99m)TcN-NOET in human leukaemic HL-60 cells is related to calcium channel activation and cell proliferation.

Guillermet S, Vuillez JP, Fontaine E, Caravel JP, Marti-Batlle D, Pasqualini R, Fagret D. Guillermet S, et al. Among authors: fagret d. Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):66-72. doi: 10.1007/s00259-005-1918-5. Epub 2005 Sep 29. Eur J Nucl Med Mol Imaging. 2006. PMID: 16193309

9

In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.

Sancey L, Ardisson V, Riou LM, Ahmadi M, Marti-Batlle D, Boturyn D, Dumy P, Fagret D, Ghezzi C, Vuillez JP. Sancey L, et al. Among authors: fagret d. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2037-47. doi: 10.1007/s00259-007-0497-z. Epub 2007 Aug 4. Eur J Nucl Med Mol Imaging. 2007. PMID: 17674000

10

N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.

Vanzetto G, Jacon P, Calizzano A, Neuder Y, Faure P, Fagret D, Machecourt J. Vanzetto G, et al. Among authors: fagret d. J Nucl Cardiol. 2007 Nov-Dec;14(6):835-42. doi: 10.1016/j.nuclcard.2007.07.011. Epub 2007 Oct 18. J Nucl Cardiol. 2007. PMID: 18022110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters